{"id":"NCT02296892","sponsor":"Paion UK Ltd.","briefTitle":"A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy","officialTitle":"A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-04","primaryCompletion":"2017-03","completion":"2017-03-13","firstPosted":"2014-11-21","resultsPosted":"2019-03-12","lastUpdate":"2020-03-18"},"enrollment":446,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Bronchoscopy"],"interventions":[{"type":"DRUG","name":"Remimazolam","otherNames":["CNS7056"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Midazolam","otherNames":["Versed"]}],"arms":[{"label":"Remimazolam","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Midazolam","type":"ACTIVE_COMPARATOR"}],"summary":"A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open label arm for midazolam, in patients undergoing a bronchoscopy.","primaryOutcome":{"measure":"Number of Participants With a Successful Procedure","timeFrame":"From first dose of study drug to removal of bronchoscope (average time not known)","effectByArm":[{"arm":"Remimazolam","deltaMin":250,"sd":null},{"arm":"Placebo","deltaMin":3,"sd":null},{"arm":"Midazolam","deltaMin":24,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":14,"countries":["United States"]},"refs":{"pmids":["30292760"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":303},"commonTop":["Hypotension","Hypertension","Diastolic hypertension","Systolic hypertension","Hypoxia"]}}